Context Therapeutics
CNTX
CNTX
52 hedge funds and large institutions have $76.4M invested in Context Therapeutics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $111M → $76.4M (-$34.7M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
52
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$15.4M | |
| 2 | +$2.26M | |
| 3 | +$994K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$732K |
| 5 |
Renaissance Technologies
New York
|
+$286K |
Top Sellers
| 1 | -$2.36M | |
| 2 | -$1.26M | |
| 3 | -$514K | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$321K |
| 5 |
ABG
Ally Bridge Group
New York
|
-$190K |